Interferon Gamma 1b
Showing 1 - 25 of 9,697
Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as
Not yet recruiting
- Chronic Pulmonary Aspergillosis
- Aspergillosis
- Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
- Antifungals as standard of care
- (no location specified)
Dec 13, 2022
Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon
Active, not recruiting
- Metastatic Myxoid Liposarcoma
- +15 more
- Interferon Gamma-1b
- +2 more
-
Palo Alto, California
- +6 more
Aug 2, 2022
Candidemia Trial in Worldwide (Interferon Gamma-1B)
Recruiting
- Candidemia
- Interferon Gamma-1B
-
Durham, North Carolina
- +4 more
Mar 14, 2022
Critically Ill Patients Trial in France, Greece, Spain (Recombinant Interferon gamma 1b (IMUKIN®), Recombinant Interferon gamma
Active, not recruiting
- Critically Ill Patients
- Recombinant Interferon gamma 1b (IMUKIN®)
- Recombinant Interferon gamma 1b placebo
-
Angers, France
- +17 more
Feb 1, 2022
HIV Trial in Philadelphia, Houston (Interferon gamma-1b)
Completed
- HIV Infections
- Interferon gamma-1b
-
Philadelphia, Pennsylvania
- +1 more
Oct 27, 2021
HIV Trial in Seattle (Tumor Necrosis Factor, Interferon gamma-1b)
Completed
- HIV Infections
- Tumor Necrosis Factor
- Interferon gamma-1b
-
Seattle, WashingtonUniv of Washington
Oct 28, 2021
Friedreich Ataxia Trial in Philadelphia (Interferon Gamma-1b)
Completed
- Friedreich Ataxia
- Interferon Gamma-1b
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 23, 2021
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
HIV Trial in New York (Zidovudine, Interferon gamma-1b)
Completed
- HIV Infections
- Zidovudine
- Interferon gamma-1b
-
New York, New YorkCornell University A2201
Oct 28, 2021
Interferon-gamma 1-b on Cells of Innate Immune System:
Completed
- Chronic Granulomatous Disease
- Interferon Gamma-1B
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jan 20, 2021
COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,
Not yet recruiting
- COPD Exacerbation Acute
- +2 more
- Interleukin-1B
- +4 more
- (no location specified)
Mar 23, 2023
Autosomal Dominant Osteopetrosis Type 2 Trial in Indianapolis (ACTIMMUNE)
Completed
- Autosomal Dominant Osteopetrosis Type 2
-
Indianapolis, IndianaIndiana University School of Medicine
Dec 11, 2020
Mycobacterium Abscessus Infection in Chronic Lung Disease and
Enrolling by invitation
- Mycobacterium Abscessus Infection
- +2 more
- Appropriate treatment
-
Pathum Wan, Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Aug 31, 2022
Asthma Trial in Atlanta (Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone)
Recruiting
- Asthma
- Albuterol Sulfate
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jul 21, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)
Recruiting
- B-cell Lymphoma
- +5 more
- Cyclophosphamide
- +3 more
-
Louisville, KentuckyNorton Cancer Institute
Jan 24, 2023
Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)
Not yet recruiting
- Melanoma
- Recombinant human interferon α1b
- +2 more
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Learn About Interferon-beta Exposure of Pregnant Women During
Not yet recruiting
- Multiple Sclerosis (MS)
- Avonex (IFNβ-1-a, Biogen Netherlands B.V)
- +5 more
-
Multiple Locations, Finland
- +1 more
Sep 19, 2023
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial
Not yet recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- +5 more
- Interferon Beta-1A
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
MCI, Amnestic Mild Cognitive Disorder Trial in Toronto (Neuro RX Gamma device, Sham Neuro RX Gamma device)
Not yet recruiting
- MCI
- Amnestic Mild Cognitive Disorder
- Neuro RX Gamma device
- Sham Neuro RX Gamma device
-
Toronto, Ontario, CanadaSt Michael's Hospital
Sep 28, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Ewing's Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Lexatumumab alone, Lexatumumab in combination, Interferon
Terminated
- Ewing's Sarcoma
- +3 more
- Lexatumumab alone
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Inherited Ophthalmic Diseases, Inherited Retinal Degeneration Trial run by the NEI (Interferon gamma-1b)
Terminated
- Inherited Ophthalmic Diseases
- Inherited Retinal Degeneration
- Interferon gamma-1b
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 5, 2019